FDA Safety Labeling Changes: Arixtra and Alora

The FDA has approved revisions to the safety labeling for fondaparinux sodium injection (Arixtra) and an extended-release estradiol transdermal system (Alora).Yael Waknine

Continue to FDA Safety Labeling Changes: Arixtra and Alora on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz